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THE EFFECT OF MARINE N-3 POLYUNSATURATED FATTY ACIDS ON
CARDIAC AUTONOMIC AND HEMODYNAMIC FUNCTION IN PATIENTS WITH
PSORIATIC ARTHRITIS: A RANDOMISED, DOUBLE-BLIND, PLACEBO-
CONTROLLED TRIAL
Salome Kristensen, Erik Berg Schmiddt, Annette Schlemmer,
Claus Rasmussen, Esther Lindgreen, Martin Berg Johansen, Jeppe
Hagstrup Christensen
Aalborg University Hospital, Aalborg, Denmark
Background: Patients with psoriatic arthritis are at high cardiovascular risk.
Marine n-3 polyunsaturated fatty acids (PUFA) may reduce the incidence of
cardiovascular disease. The aim of this study was to investigate the effect of
marine n-3 PUFA on cardiac autonomic function and vascular function in pa-
tients with psoriatic arthritis.
Methods: The study was conducted as a randomized, double-blind, placebo-
controlled trial, where 145 patients with psoriatic arthritis were supple-
mented with 3 g of n-3 PUFA or olive oil (control) daily for 24 weeks. Blood
pressure, heart rate, HRV, central blood pressure, pulse wave velocity (PWV)
and fatty acid composition of granulocytes, were determined.
Results: At baseline we found a significant difference in the HRV parameter RR
when comparing subjects with the highest vs the lowest fish intake (pZ 0.03).
After supplementation for 24weeks therewasa trend towards an increase in RR
(pZ 0.13) and decrease in heart rate (pZ 0.12) comparing the n-3 PUFA group
with the control group. However, per-protocol analysis (performed on partic-
ipants who completed the trial with a good compliance) showed significantly
increased RR (p Z 0.01) and lowered heart rate (p Z 0.01) in the n-3 PUFA
supplemented patients compared to controls. Blood pressure, PWVand central
blood pressure did not change after supplementation with n-3 PUFA.
Conclusions: Marine n-3 PUFA increased HRV in patients with psoriatic
arthritis which may suggest a protective effect of n-3 PUFA against cardio-
vascular disease in this population.7.8
ARTERIAL STIFFNESS AND SYSTEMIC INFLAMMATION IN COPD PATIENTS
Renata Marietta Bocskei 1, Lilla Tamasi 1, Bela Benczur 3, Attila Cziraki 2,
Gyorgy Losonczy 1, Aniko Bohacs 1
1Semmelweis University, Department of Pulmonology, Budapest, Hungary
2University of Pecs, Hungary Heart Institute, Pecs, Hungary
3Hetenyi Geza Hospital, Department of Cardiology, Szolnok, Hungary
Background: COPD is one of the leading causes of mortality worldwide. Sys-
temic low-grade inflammation is a common finding in COPD. Soluble uroki-
nase-type plasminogen activator receptor (suPAR) indicates an
inflammatory state and it has an association with atherosclerosis and cardio-
vascular disease (CVD). ThesuPAR reflects different aspects of inflammation
as high sensitive C-reactive protein (hsCRP) and IL-6. Elevated CVD risk is
observed in COPD. However the correlation between COPD and arterial stiff-
ness is rarely investigated in the literature.
We investigated the association between some inflammatory biomarkers
(suPAR, IL-6, hsCRP) and arterial stiffness in COPD and control patients.
Methods: We measured 45 middle aged individuals (25 COPD and 20 control
normotensive patients) without diabetes and cardiovascular disease. IL-6,
hsCRP, suPAR were determined in fasting blood samples. Whole body pleth-
ysmography, assessment tests and aortic pulse wave velocity (aoPWV),
augmentation index (Aix), central systolic blood pressure (cSBP) were deter-
mined. COPD patients were categorized according to GOLD-classification.
Results: Patients with COPD have a higher level of IL-6 (5.38 vs 3.63 pg/ml
pZ0.022), suPAR (2.84 vs 2.41 ng/ml pZ0.036), and hsCRP (2.99 vs 1.91
mg/L pZ0.068). The patients with COPD have a significant higher aoPWV
(pZ0.002), and cSBP (pZ0.022).
Conclusion: In this study we found elevated inflammatory markers and
aoPWV in COPD patients, both of them indicate the presence of earlier
atherosclerosis than in controls without COPD.7.9
CAROTID ARTERY STIFFNESS IS ASSOCIATED WITH CT-MEASURED LUNG
AIR-TRAPPING IN COPD PATIENTS AND CONTROLS INDEPENDENT OF AGE,
BLOOD PRESSURE AND SMOKING HISTORY
Gary Pierce, John Newell, Alejandro Comellas, Eric Hoffman, Kelsey Warner,
Anna Croghan, Lyndsey DuBose, Peg Nopoulos, Vince Magnotta,Stephan Arndt, Karin Hoth
University of Iowa, Iowa City, USA
Background: Early stages of chronic obstructive pulmonary disease (COPD)
are characterized by loss of the terminal bronchioles and ‘air trapping’ often
before overt emphysema manifests (1). COPD patients are also at risk for
cardiovascular disease (CVD), therefore, we hypothesized that the degree
of air trapping on computed tomography (CT) (2) would be associated with
higher aortic (carotid femoral pulse wave velocity, CFPWV) and carotid ar-
tery stiffness (b-stiffness), biomarkers of CVD risk.
Methods: Ten adults with COPD but little emphysema (age 668 yrs, 5F/5M,
GOLD stage 1-3) and 9 adults without COPD (age 5913 yrs, 5F/4M) that had
a research chest CT were recruited.
Results: COPD patients had greater smoking history (45.9  21 vs. 6.4  12.9
pack-years, P<0.001) and air trapping (0.85 0.07 vs. 0.78 0.05 Expira-
tion/Inspiration attenuation ratio, p<0.05) (2) compared with non-COPD
subjects, but did not differ by age, BMI, SaO2%, brachial BP or % emphysema
(all p>0.05). COPD patients had significantly higher CFPWV (999 293 vs.
760 147 cm/sec, p<0.05) but not carotid b-stiffness (13.3 5.1 vs. 10.6
4.7 U, pZ0.26). In the entire cohort (nZ19), air trapping was associated
with higher CFPWV (rZ0.60, p<0.01) and carotid b-stiffness (rZ0.75,
p<0.001). After adjustment for age, mean BP and pack-years, the correla-
tion between carotid b-stiffness and air-trapping remained significant
(rZ0.68, p<0.01).
Conclusions: Carotid artery stiffness is significantly associated with air trap-
ping in COPD patients and controls, independent of age, smoking history and
BP. This suggests a link between high CVD risk in COPD patients with small
airway disease without predominant emphysema.
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AORTIC STIFFNESS AND BODY MASS INDEX (BMI) IN CHRONIC
OBSTRUCTIVE PULMONARY DISEASE (COPD)
Nichola Gale 1, Ali Albarrati 1, Margaret Munnery 2, Dennis Shale 3,
John Cockcroft 2
1Cardiff University, Cardiff, UK
2Cardiff Metropolitan University, Cardiff, UK
3GSK, Uxbridge, UK
Background: Patients with COPD have increased Cardiovascular (CV) risk and
commonly present with altered body composition. Patients with COPD and a
low BMI have poorer health outcomes1, while obesity may increase CV risk2.
The aim of this analysis was to explore BMI, CV risk, exercise capacity and
systemic inflammation in COPD.
Methods: This analysis included 524 stable patients with COPD (confirmed
with spirometry) from the ARCADE (Assessment of Risk in Chronic Airways
Disease Evaluation) study. Assessments included lung function (forced expi-
ratory volume in 1 second (FEV1)), smoking history, BMI, aortic pulse wave
velocity (PWV) (SphygmoCor device), blood pressure (BP), 6-minute walking
distance (6MWD). Inflammation was measured by high sensitivity C-reactive
protein (HsCRP) and fibrinogen. Patients were classified by BMI as follows:
low (<19.9 Kgm2), healthy (20-24.9Kgm2), overweight (25-29.9Kgm2) obese
(>30Kg/m2).
Results: There was no difference in gender, age, lung function or smoking
history between patients grouped according to BMI. However, there was a
difference in PWV, systolic BP, 6MWD and inflammation between the groups
(p<0.05). The difference in PWV remained after adjustment for age and
mean BP (Table 1). Overweight and obese patients (BMI <25) had greater
PWV and inflammation, while obese patients had the poorest 6MWD.
Conclusions: The findings suggest obese patients with COPD have greater CV
risk which may be a result of poorer physical capacity and greater inflamma-
tion. Optimisation of BMI in COPD may improve outcomes further follow-up
of this cohort will evaluate the prognostic value of arterial stiffness and
possible therapeutic targets.
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ARTERIAL STIFFNESS, BLOOD PRESSURE AND CARDIAC OUTPUT STUDY
Suzanne Holewijn, Erik Groot Jebbink, Wim Aengevaeren, Jasper Martens,
Marcel Hovens, Michel Reijnen
Rijnstate Hospital, Arnhem, Netherlands
We are planning a prospective study in 200 patients with an abdominal artery
aneurysm (AAA). Non-invasive measurements will be performed including
tonometry-based pulse wave analysis (PWA) and pulse wave velocity (PWV),
echocardiography, and 24-hour blood pressure measurements.
This study will provide insight in how PWV/PWA-parameters can help identify
characteristics of prostheses used to treat AAA that best match native aortic
characteristics and will lead to the best long-term outcome after aneurysm
repair. Also the interaction between blood pressure (and control) and cardiac
output will be evaluated. These results will form the basis for evidence-based
practice for stent choice and lead to better outcomes after AAA treatment.
First we will validate non-invasive against invasive central pressure in 20
patients treated with endovascular aneurysm repair (EVAR).
This study will provide insight if arterial stiffness parameters change over
time after treatment of AAA and the possible role of PWV/PWA for the
surveillance after treatment. We expect to provide insight in the various
determinants of the PWV/PWA-parameters pre- and post-repair of AAA
evaluation also includes graft material, intraluminal thrombus, and inflam-
mation. We will study whether the different PWV/PWA parameters predict
outcome after AAA repair for different prostheses.
Finally, this study will reveal whether parameters of cardiac output obtained
by tonometry correspond with parameters obtained by echocardiography in
AAA patients. If so, the PWV/PWA measurement can detect cardiologic
problems at an early stage during follow-up. By early treatment, the
development of heart failure can be delayed or even prevented. We look
forward to input on our study-plan.Table: Mean day and night values for peripheral systolic blood pres-
sure (pSBP), peripheral diastolic blood pressure (pDBP), central systolic
blood pressure (cSBP), central diastolic blood pressure (cDBP), heart
rate (HR), augmentation index (AIx, AIx75) and reflection magnitude
(RM) * marks a significant difference between day and night (t-test,
p<0.05).
20e29 years 30e49 years 50e69 years
Day Night Day Night Day Night
pSBP (mmHg) 118.8 * 103.4 124.8 * 109.0 123.0 * 105.8
pDBP (mmHg) 75.7 * 59.5 81.4 * 64.2 79.6 * 64.8
cSBP (mmHg) 106.3 * 97.1 114.8 * 103.3 114.5 * 100.7
cDBP (mmHg) 77.4 * 60.6 83.1 * 65.3 81.1 * 65.6
HR (bpm) 76.0 * 59.6 77.5 * 64.4 70.4 * 59.8
AIx 18.2 19.0 19.7 22.7 25.9 * 35.0
AIx75 19.3 * 10.4 20.6 15.7 23.4 26.4
RM 55.2 * 63.2 59.7 * 68.8 62.3 * 71.58.3
QUANTIFYING HEART AND ARTERIAL CONTRIBUTIONS TO CENTRAL
BLOOD PRESSURE IN SYSTOLE
Samuel Vennin, Ye Li, Marie Willemet, Henry Fok, Brian Clapp,
Jordi Alastruey, Phil Chowienczyk
King’s College London, UK
Background: A recent study has shown that the central pressure waveform
could be determined by a very small set of parameters accounting for the
physical properties of the heart and the arteries [1]. Particularly, main pres-
sure features like first systolic shoulder (P1) and systolic (P2) pressures were
estimated accurately.
Methods: By combining a numerical virtual population (nZ3,325) similar
to [2] and experimental data acquired from a pressure/Doppler flow veloc-
ity transducer place in the ascending aorta in 18 patients (meanSD: age
6311 yr, aortic BP 13623/7313 mmHg) at the time of cardiac catheter-
ization, we assessed the accuracy of those predictions for magP1 (P1-DBP)
and P2 using respectively a water hammer [3] and a 3-element Windkessel
models [4]. Contributions of the heart and arterial properties to these es-
timates though respectively blood velocity, volume and pulse wave veloc-
ity, compliance, resistance were then derived from the theoretical models
used.
Results: P1 and P2 estimates agreed well with theoretical pressure both in
the numerical dataset (mean+/-SD difference, 1.13.2 mmHg and
-1.63.1 mmHg respectively) and the clinical cohort (mean+/-SD difference,
-2.45.5 mmHg and 1.96.5 mmHg respectively). The ratio arterial-to-
heart contribution has been shown to be fairly constant as magP1 was
increasing.
Conclusions: Arteries and heart contribute as much to rise in P1. More clin-
ical data are being collected to quantify the contributions of the heart and
arteries to P2.
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DIURNAL CHANGES IN CENTRAL PRESSURE AND PULSE WAVE
PARAMETERS IN HEALTHY SUBJECTS
Bernhard Hametner 1, Christopher Mayer 1, Jelena Ko¨ster 2,
Johannes Weber 1, Michael Reppel 4, Klaas Franzen 5, Eugenijus Kaniusas 3,
Siegfried Wassertheurer 1, Kai Mortensen 6
1AIT Austrian Institute of Technology, Health & Environment Department,
Vienna, Austria
2Medical University of Schleswig-Holstein, Medical Clinic II, Lu¨beck,
Germany
3Vienna University of Technology, Institute of Electrodynamics, Microwave
and Circuit Engineering, Vienna, Austria
4Cardiology Landsberg, Landsberg, Germany
5Medical University of Schleswig-Holstein, Medical Clinic III, Lu¨beck,
Germany
6Cardiology Practice, Kiel, Germany
Purpose: The feasibility of pulse wave analysis (PWA) over 24 hours with
oscillometric devices has already been shown and first studies indicate addi-
tional information compared to single measurements. Nevertheless, diurnal
patterns of PWA parameters in healthy subjects, which can potentially serve
as a reference, are currently missing. Therefore, the aim of this study was to
perform 24h-PWA measurements in healthy subjects over a wide age range
and to analyse day/night differences.
Methods: 91 well defined healthy subjects underwent 24h PWA measure-
ments using the Mobil-O-Graph device (IEM, Germany). The subjects were
categorized in three age groups (20-29 years, 30-49 years, 50-69 years). Day-
time (9-21h) and nighttime (0-6h) averages were calculated.
Results: A significant dipping behaviour in all age groups could be found for
diastolic blood pressure (> 14 mmHg in all age groups, p<0.05), peripheral
systolic blood pressure (> 15 mmHg, p<0.05) and central systolic blood pres-
sure (> 9 mmHg, p<0.05). A significant rising effect in all age groups was
found for the reflection magnitude (> 8 %). In contrast, the day/night differ-
ence in augmentation index was age dependent and this dependency
remained also for AIx75, see table.
Conclusions: Prominent pressure dipping and a rise in reflection magnitude
were present in all age groups during nighttime, while diurnal changes in
augmentation index showed an age-dependency. This differing behaviour
of PWA parameters should be investigated in further studies. Furthermore,
the observed effects of diurnal changes in healthy subjects may provide a
basis for reference profiles for future patient evaluation.
